Literature DB >> 30720478

Therapeutic noninvasive brain stimulation in Alzheimer's disease and related dementias.

Stephanie S Buss1, Peter J Fried1, Alvaro Pascual-Leone1,2.   

Abstract

PURPOSE OF REVIEW: Alzheimer's disease is a progressive neurodegenerative disease without effective pharmacological treatment. Noninvasive brain stimulation (NIBS) techniques, such as repetitive transcranial magnetic stimulation (TMS) and transcranial electrical stimulation (tES), are increasingly being investigated for their potential to ameliorate the symptoms of Alzheimer's disease and related dementias (ADRD). RECENT
FINDINGS: A comprehensive literature review for primary research reports that investigated the ability of TMS/tES to improve cognition in ADRD patients yielded a total of 20 reports since 2016. Eight studies used repetitive TMS and 12 used transcranial direct current stimulation, the most common form of tES. Eight of the studies combined NIBS with cognitive training. Promising results should encourage continued investigation, however there is currently insufficient evidence to support widespread adoption of NIBS-based clinical treatments for ADRD.
SUMMARY: NIBS remains an active area of investigation for treatment of ADRD, though the predominance of small, heterogeneous, proof-of-principle studies precludes definitive conclusions. We propose the establishment of a consortium to achieve the benefits of large-scale, controlled studies using biomarker-based diagnostic characterization of participants, development of neurophysiological markers to verify target engagement, and standardization of parameters.

Entities:  

Mesh:

Year:  2019        PMID: 30720478      PMCID: PMC7659470          DOI: 10.1097/WCO.0000000000000669

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  66 in total

1.  Impaired LTP- but not LTD-like cortical plasticity in Alzheimer's disease patients.

Authors:  Giacomo Koch; Francesco Di Lorenzo; Sonia Bonnì; Viviana Ponzo; Carlo Caltagirone; Alessandro Martorana
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Effects of Transcranial Direct Current Stimulation on Episodic Memory in Amnestic Mild Cognitive Impairment: A Pilot Study.

Authors:  Rosa Manenti; Marco Sandrini; Elena Gobbi; Giuliano Binetti; Maria Cotelli
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2020-08-13       Impact factor: 4.077

Review 3.  Aerobic exercise effects upon cognition in Mild Cognitive Impairment: A systematic review of randomized controlled trials.

Authors:  D M Cammisuli; A Innocenti; F Franzoni; C Pruneti
Journal:  Arch Ital Biol       Date:  2017-07-01       Impact factor: 1.000

4.  Transcranial magnetic stimulation improves naming in Alzheimer disease patients at different stages of cognitive decline.

Authors:  M Cotelli; R Manenti; S F Cappa; O Zanetti; C Miniussi
Journal:  Eur J Neurol       Date:  2008-12       Impact factor: 6.089

5.  Transcranial magnetic stimulation predicts cognitive decline in patients with Alzheimer's disease.

Authors:  Caterina Motta; Francesco Di Lorenzo; Viviana Ponzo; Maria Concetta Pellicciari; Sonia Bonnì; Silvia Picazio; Nicola Biagio Mercuri; Carlo Caltagirone; Alessandro Martorana; Giacomo Koch
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-07-21       Impact factor: 10.154

Review 6.  A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.

Authors:  Simona Gabriella Di Santo; Federica Prinelli; Fulvio Adorni; Carlo Caltagirone; Massimo Musicco
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

7.  BOLD MRI responses to repetitive TMS over human dorsal premotor cortex.

Authors:  Sven Bestmann; Jürgen Baudewig; Hartwig R Siebner; John C Rothwell; Jens Frahm
Journal:  Neuroimage       Date:  2005-07-05       Impact factor: 6.556

8.  Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Authors:  Stephen Salloway; Reisa Sperling; Nick C Fox; Kaj Blennow; William Klunk; Murray Raskind; Marwan Sabbagh; Lawrence S Honig; Anton P Porsteinsson; Steven Ferris; Marcel Reichert; Nzeera Ketter; Bijan Nejadnik; Volkmar Guenzler; Maja Miloslavsky; Daniel Wang; Yuan Lu; Julia Lull; Iulia Cristina Tudor; Enchi Liu; Michael Grundman; Eric Yuen; Ronald Black; H Robert Brashear
Journal:  N Engl J Med       Date:  2014-01-23       Impact factor: 91.245

9.  Reproducibility of Single-Pulse, Paired-Pulse, and Intermittent Theta-Burst TMS Measures in Healthy Aging, Type-2 Diabetes, and Alzheimer's Disease.

Authors:  Peter J Fried; Ali Jannati; Paula Davila-Pérez; Alvaro Pascual-Leone
Journal:  Front Aging Neurosci       Date:  2017-08-21       Impact factor: 5.750

Review 10.  Can transcranial electric stimulation with multiple electrodes reach deep targets?

Authors:  Yu Huang; Lucas C Parra
Journal:  Brain Stimul       Date:  2018-09-26       Impact factor: 8.955

View more
  16 in total

1.  Improving autobiographical memory in Alzheimer's disease by transcranial alternating current stimulation.

Authors:  Lucie Bréchet; Christoph M Michel; Daniel L Schacter; Alvaro Pascual-Leone
Journal:  Curr Opin Behav Sci       Date:  2021-02-14

Review 2.  Assessing the mechanisms of brain plasticity by transcranial magnetic stimulation.

Authors:  Ali Jannati; Lindsay M Oberman; Alexander Rotenberg; Alvaro Pascual-Leone
Journal:  Neuropsychopharmacology       Date:  2022-10-05       Impact factor: 8.294

Review 3.  Toward noninvasive brain stimulation 2.0 in Alzheimer's disease.

Authors:  Arianna Menardi; Simone Rossi; Giacomo Koch; Harald Hampel; Andrea Vergallo; Michael A Nitsche; Yaakov Stern; Barbara Borroni; Stefano F Cappa; Maria Cotelli; Giulio Ruffini; Georges El-Fakhri; Paolo M Rossini; Brad Dickerson; Andrea Antal; Claudio Babiloni; Jean-Pascal Lefaucheur; Bruno Dubois; Gustavo Deco; Ulf Ziemann; Alvaro Pascual-Leone; Emiliano Santarnecchi
Journal:  Ageing Res Rev       Date:  2021-12-30       Impact factor: 11.788

Review 4.  Invasive and non-invasive therapies for Alzheimer's disease and other amyloidosis.

Authors:  Gaurav Pandey; Vibin Ramakrishnan
Journal:  Biophys Rev       Date:  2020-09-15

5.  Can Pharmacological Augmentation of Cognitive Training Remediate Age-Related Cognitive Decline?

Authors:  Jason Smucny; Cameron S Carter
Journal:  Am J Psychiatry       Date:  2020-06-01       Impact factor: 19.242

Review 6.  Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update.

Authors:  Manuela Pennisi; Giuseppe Lanza; Mariagiovanna Cantone; Emanuele D'Amico; Francesco Fisicaro; Valentina Puglisi; Luisa Vinciguerra; Rita Bella; Enzo Vicari; Giulia Malaguarnera
Journal:  Nutrients       Date:  2020-05-12       Impact factor: 5.717

Review 7.  Transcranial Magnetic Stimulation in Alzheimer's Disease: Are We Ready?

Authors:  Marina Weiler; Kevin C Stieger; Jeffrey M Long; Peter R Rapp
Journal:  eNeuro       Date:  2020-01-07

8.  Repetitive transcranial magnetic stimulation increases the brain's drainage efficiency in a mouse model of Alzheimer's disease.

Authors:  Yangyang Lin; Jian Jin; Rongke Lv; Yuan Luo; Weiping Dai; Wenchang Li; Yamei Tang; Yuling Wang; Xiaojing Ye; Wei-Jye Lin
Journal:  Acta Neuropathol Commun       Date:  2021-06-02       Impact factor: 7.801

9.  Corticomotor Plasticity Predicts Clinical Efficacy of Combined Neuromodulation and Cognitive Training in Alzheimer's Disease.

Authors:  Anna-Katharine Brem; Riccardo Di Iorio; Peter J Fried; Albino J Oliveira-Maia; Camillo Marra; Paolo Profice; Davide Quaranta; Lukas Schilberg; Natasha J Atkinson; Erica E Seligson; Paolo Maria Rossini; Alvaro Pascual-Leone
Journal:  Front Aging Neurosci       Date:  2020-07-08       Impact factor: 5.750

10.  Intracranial alternating current stimulation facilitates neurogenesis in a mouse model of Alzheimer's disease.

Authors:  Qian Liu; Yihang Jiao; Weijian Yang; Beiyao Gao; Daniel K Hsu; Jan Nolta; Michael Russell; Bruce Lyeth; Theodore P Zanto; Min Zhao
Journal:  Alzheimers Res Ther       Date:  2020-07-23       Impact factor: 8.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.